Ken Griffin’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-415,951
Closed -$3.95M 5931
2025
Q1
$3.95M Buy
415,951
+150,709
+57% +$1.43M ﹤0.01% 1957
2024
Q4
$3.66M Buy
+265,242
New +$3.66M ﹤0.01% 2045
2024
Q3
Sell
-66,914
Closed -$319K 5876
2024
Q2
$319K Buy
66,914
+36,111
+117% +$172K ﹤0.01% 4249
2024
Q1
$209K Buy
+30,803
New +$209K ﹤0.01% 4746
2023
Q4
Sell
-20,861
Closed -$71.3K 5954
2023
Q3
$71.3K Sell
20,861
-24,787
-54% -$84.8K ﹤0.01% 4964
2023
Q2
$218K Buy
45,648
+30,672
+205% +$147K ﹤0.01% 4381
2023
Q1
$63.2K Sell
14,976
-12,335
-45% -$52.1K ﹤0.01% 5081
2022
Q4
$105K Sell
27,311
-8,927
-25% -$34.5K ﹤0.01% 4991
2022
Q3
$217K Sell
36,238
-10,614
-23% -$63.6K ﹤0.01% 4801
2022
Q2
$163K Sell
46,852
-11,755
-20% -$40.9K ﹤0.01% 5081
2022
Q1
$201K Sell
58,607
-21,231
-27% -$72.8K ﹤0.01% 5311
2021
Q4
$234K Sell
79,838
-31,712
-28% -$92.9K ﹤0.01% 5350
2021
Q3
$448K Buy
111,550
+41,891
+60% +$168K ﹤0.01% 4645
2021
Q2
$357K Buy
69,659
+23,361
+50% +$120K ﹤0.01% 5039
2021
Q1
$217K Buy
46,298
+9,595
+26% +$45K ﹤0.01% 5340
2020
Q4
$126K Buy
36,703
+1,256
+4% +$4.31K ﹤0.01% 4624
2020
Q3
$186K Buy
35,447
+5,094
+17% +$26.7K ﹤0.01% 4116
2020
Q2
$140K Buy
30,353
+6,474
+27% +$29.9K ﹤0.01% 4170
2020
Q1
$28K Buy
23,879
+12,479
+109% +$14.6K ﹤0.01% 4615
2019
Q4
$15K Buy
+11,400
New +$15K ﹤0.01% 4538
2019
Q2
Sell
-7,701
Closed -$36K 4661
2019
Q1
$36K Buy
7,701
+4,396
+133% +$20.6K ﹤0.01% 4312
2018
Q4
$14K Buy
3,305
+1,658
+101% +$7.02K ﹤0.01% 4352
2018
Q3
$17K Buy
+1,647
New +$17K ﹤0.01% 4155
2018
Q1
Sell
-1,001
Closed -$16K 3996
2017
Q4
$16K Buy
+1,001
New +$16K ﹤0.01% 3791
2016
Q4
Sell
-2,817
Closed -$93K 3607
2016
Q3
$93K Buy
+2,817
New +$93K ﹤0.01% 3210